Sorrento Therapeutics (SRNE) – All Earnings Related News
-
Sorrento Therapeutics' (SRNE) Scilex Reports March 2022 Prelim ZTlido Sales of $8.1M, $18.4M For Q1 2022
-
Sorrento's (SRNE) Scilex Announces Continuous Sales Growth in ZTlido and Expects to Complete Enrollment on its SP-102 Phase 3 Pivotal Trial Program in 2020
-
-
-
-
-
-
-
Back to SRNE Stock Lookup